Cinacalcet Hydrochloride

盐酸西那卡塞

Report date: 2026/05/25 20:02:40
NMEFirst In Class

Base Information

Drug NameCinacalcet Hydrochloride
Drug Alias NameCinacalcetum盐酸西那卡塞特西那卡塞PararegSensipar +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium sensing receptor agonists
TargetsCalcium sensing receptor
Therapy Area/IndicationsRejection of renal transplantationHyperparathyroidism, SecondaryHyperparathyroidism, Primary +[16] 
Global Approved IndicationsHyperparathyroidism, SecondaryHyperparathyroidismHypercalcemia
Approved Indications in ChinaHyperparathyroidism, SecondaryHyperparathyroidismHypercalcemia
Original Approved Country/TerritoryUnited States
Original Approved Date2004/03/08
Country/TerritoryCzechiaBelgiumCanada +[28] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Hakko Kirin Co LtdKyowa Hakko Kogyo Co Ltd
Inactive CompaniesKyowa Kirin Co LtdWake Forest University Health SciencesDompe Farmaceutici Spa +[7] 
Active IndicationsHyperparathyroidism, SecondaryHyperparathyroidismHypercalcemia
Inactive IndicationsRejection of renal transplantationHyperparathyroidism, PrimaryHypophosphatemia +[13] 

Other Information

ATC CodeH05BX01
Related LinksWikipediaDrugBankKEGG